Aims & Scope
Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of genetic diseases. Cell therapy manuscripts can also include application in non-genetic diseases when cells have been genetically modified. Current Gene Therapy publishes reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of genetic diseases.
Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.
Ranking and Category
81st of 167 in Genetics & Heredity
Bentham Press Release — NEWS
- Free Trial Request
- Most Accessed Article : Immune Responses to AAV in Clinical Trials
- Most Cited Article: Clinical Immunotherapy of B-Cell Malignancy Using CD19-Targeted CAR T-Cells
- Free Trial Request
- Most Accessed Article: Prospects and Limitations of T Cell Receptor Gene Therapy
- Open Access Article: Tet-On Systems For Doxycycline-inducible Gene Expression
- Call For Paper
- New Issue Published Current Gene Therapy Vol. 17 Issue 2
- New Issue Published Current Gene Therapy Vol. 17 Issue 1
- Most Accessed Article:A Simple High Efficiency Intra-Islet Transduction Protocol Using Lentiviral Vectors
- Open Access Article: Gene Electrotransfer: A Mechanistic Perspective
- Call For Paper
- Free Trial Request
- Most Accessed Article Prospects and Limitations of T Cell Receptor Gene Therapy
- Open Access Article: Tet-On Systems For Doxycycline-inducible Gene Expression
- Call For Paper
- Free Trial Request
- Open Access Article: Manufacturing and Regulatory Strategies for Clinical AAV2-hRPE65
- Most Accessed Article: A Simple High Efficiency Intra-Islet Transduction Protocol Using Lentiviral Vectors
- New Issue Published Current Gene Therapy Vol. 16 Issue 6
- Call For Paper
- Free Trial Request
- Open Access Article: Tet-On Systems For Doxycycline-inducible Gene Expression
- Most Accessed Article: Tet-On Systems For Doxycycline-inducible Gene Expression
- New Issue Published Current Gene Therapy Vol. 16 Issue 5
- Free Online Issue Current Gene Therapy Vol. 16 Issue 1
- Call For Paper
- Free Trial Request
- Most Accessed Article: AAV Vectorization of DSB-mediated Gene Editing Technologies
- Highlighted Article: Rational Autologous Cell Sources For Therapy of Heart Failure – Vehicles and Targets For Gene and RNA Therapies
- Most Cited Article: Targeted Genome Editing Tools for Disease Modeling and Gene Therapy
- Most Accessed Article: Tet-On Systems For Doxycycline-inducible Gene Expression
- Call For Paper
- Free Trial Request
- New Issue Published Current Gene Therapy Vol.16 Issue 4
- Podcast for (Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1)
- Free Online Issue of Current Gene Therapy
- Highlighted Article: Gene Electrotransfer: A Mechanistic Perspective
- Free Trial Request
- Call For Paper
- Highlighted Article: Seq and You Will Find
- Most Accessed Article: AAV Vectorization of DSB-mediated Gene Editing Technologies
- Free Trial Offer
-
A Short Video on Bentham Science Flagship Journal Current Gene Therapy
-
Bentham Open Access Plus Article From the Journal Current Gene Therapy
- Rational autologous cell sources for therapy of heart failure
- Chromatin remodeling proteins: New insights in human malignancy and targeted cancer therapy
-
Recently Published Issue of the Journal in Current Gene Therapy
-
Contributions by Japanese Authors in Bentham Science Journal ‘Current Gene Therapy’
-
Highlighted Article Flyer for the journal “Current Gene Therapy”Volume 16, Number 1
